Please assess the completion status of the following clinical trial:

Trial Title: Protecting Our Community: COVID-19 Testing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years old or older~* Member of study community~* No current significant symptoms consistent with COVID-19~Exclusion Criteria:~* \< 18 years old~* Not a member of the study community~* Current significant symptoms consistent with COVID-19

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Active delivery (Type: EXPERIMENTAL): For the participants randomized to the active arm will have their home collection kit registered on their behalf by bilingual (Spanish and English) community health workers, who are trusted community members. Home testing kits augmented with study developed materials will direct participants to contact the study team for assistance.
- Passive delivery (Type: EXPERIMENTAL): Participants randomized to the passive arm will receive a home test kit augmented with instructions on how to self-register their kit online, and will be directed to contact Everlywell for assistance, if needed.

Based on this trial design, predict the completion outcome and termination type (if applicable).